找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪(fǎng)問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Genotype Phenotype Coupling; Methods and Protocol Stefan Zielonka,Simon Krah Book 2023Latest edition The Editor(s) (if applicable) and The

[復(fù)制鏈接]
樓主: Suture
11#
發(fā)表于 2025-3-23 18:55:28 | 只看該作者
12#
發(fā)表于 2025-3-24 01:31:18 | 只看該作者
13#
發(fā)表于 2025-3-24 02:21:44 | 只看該作者
Die Scheibe gleicher Festigkeit,thods for characterizing kinase–substrate interactions are limited by their inherently low throughput and the heterogeneity of samples analyzed. Recent advances in yeast surface display techniques provide new opportunities for studying individual kinase–substrate interactions in a stimulus-independe
14#
發(fā)表于 2025-3-24 09:06:23 | 只看該作者
https://doi.org/10.1007/978-3-642-91141-5pproved in 2018, a major drawback that remains is the time-consuming reformatting of monoclonal antibody (mAb) candidates. By using a Golden Gate cloning (GGC)-dependent workflow, the?bulk transfer of genetic information can be performed from antibody fragments displayed on yeast cells to a bidirect
15#
發(fā)表于 2025-3-24 10:58:21 | 只看該作者
https://doi.org/10.1007/978-3-662-42546-6e recombinant antibody library approaches is ongoing, the major source of antibody-secreting cells (ASCs) remains to be primary B cells of mostly rodent origin. As fainting viability and secretion rates can lead to false-negative screening results, careful preparation of these cells is an essential
16#
發(fā)表于 2025-3-24 17:00:49 | 只看該作者
17#
發(fā)表于 2025-3-24 21:56:56 | 只看該作者
https://doi.org/10.1007/978-3-7091-9980-0biotherapeutics. Besides random integration methods, targeted gene integration approaches have emerged as promising tools over the last few years. In addition to reducing heterogeneity within a pool of recombinant transfectants, this process can also facilitate shorter timelines of the current cell
18#
發(fā)表于 2025-3-25 01:16:18 | 只看該作者
https://doi.org/10.1007/978-1-0716-3279-6Antibodies; Natively paired antibody libraries; Single cell technologies; Therapeutics; Antibody enginee
19#
發(fā)表于 2025-3-25 06:16:50 | 只看該作者
978-1-0716-3281-9The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Science+Busines
20#
發(fā)表于 2025-3-25 11:06:02 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 05:22
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
花莲市| 营口市| 鲁山县| 五家渠市| 玛纳斯县| 东乡县| 龙江县| 屏边| 聂拉木县| 永安市| 江永县| 苍梧县| 婺源县| 永兴县| 腾冲县| 盐亭县| 富宁县| 汨罗市| 舟山市| 富阳市| 景洪市| 西峡县| 阳东县| 尚志市| 和静县| 九江市| 古浪县| 修水县| 北流市| 罗江县| 罗城| 临朐县| 信丰县| 二连浩特市| 饶河县| 定结县| 盖州市| 赣州市| 扶绥县| 延长县| 上虞市|